In this 30-second preview, Director of Chemistry and Analytics at Charles River, Russell Scammell, describes how triaging a hit compound for its pharmaceutics, formulation, and stability characteristics early in the discovery process saves time and money across an overall program. Russell and the rest of the early discovery team explain the advantages of Charles River’s integrated approach to drug discovery in the full-length Evolution of a Compound video. Watch the feature at https://bit.ly/3dKuJLh.
For over 70 years, Charles River has provided essential products and services to help pharmaceutical and biotechnology companies, government agencies, and leading academic institutions around the globe, helping to accelerate their research and drug development efforts. With over 90 sites globally, we’re ready to tackle your product’s most unique challenges. Our focus on timeliness and accuracy in every stage of drug development means you can count on us to deliver reliable results – every step of the way.
Visit our website to learn more about our portfolio and how we can support your research. https://bit.ly/2RTdGOU